Conformational Plasticity in Amyloid Assemblies: A Paradigm Shift from Structural Rigidity to Functional Adaptability

TL;DR

This paper shows how amyloid assemblies can change shape, challenging the idea that they are structurally rigid and suggesting they can adapt functionally.

Contribution

The study introduces a new perspective on amyloid assemblies by demonstrating their conformational plasticity using advanced imaging techniques.

Findings

hIAPP conformational ensembles vary with mutations and PTMs.

Scanning tunneling microscopy reveals structural diversity in amyloid assemblies.

Findings suggest amyloid assemblies are functionally adaptable rather than rigid.

Abstract

The
divergence of conformational ensembles of hIAPP in response to different
types of mutations and PTMs has been decoded by leveraging
the scanning tunneling microscopy-based probability interpretation
technique.

Figures

Full text

The classical paradigm in structural biology, rooted in the “one sequence, one structure, one function” dogma, has long portrayed proteins as static entities adopting singular, thermodynamically stable conformations to execute defined biological roles.? This view, largely shaped by early X-ray crystallography studies, emphasizes structural rigidity as a prerequisite for functional specificity. For instance, classical models consider amyloid aggregates as rigid, highly ordered β-sheet assemblies, with subunit conformations within a given β-sheet considered identical (Figure). However, the debut of advanced techniques like nuclear magnetic resonance (NMR) and cryo-electron microscopy (cryo-EM) has unveiled a hidden dimension of protein behaviorconformational heterogeneity. ?−?

Mutations and post-translational modifications (PTMs) amplify this diversity, acting as molecular perturbations that reshape energy landscapes and exponentially expand the structural and functional repertoires encoded within these ensembles.? This paradigm shift casts conformational plasticity not as a biological anomaly but as a fundamental driver of protein evolution and adaptability.

hIAPP, misfolding into β-sheet-rich aggregates, is linked to type 2 diabetes. The authors show that wild-type hIAPP adopts 17 coexisting conformational substates interconnected by 60 distinct interstrand interaction modes, forming a dynamic “conformational ecosystem”.? Their findings challenge the traditional view of amyloids as rigid, ordered fibrils. To probe how genetic and post-translational variations modulate this system, the team analyzed four hIAPP variants: the disease-associated mutant (hIAPP S20G), the terminus-substituted mutant (hIAPP COOH), the multiple-site mutant (rIAPP R18H), and the artificial mutant carrying PTM (hIAPP S20p).

The results are striking in their bidirectional complexity.? While the S20G mutation and COOH terminus substitution reduce conformational diversity (to 15 and 12 substates, respectively), phosphorylation at S20 expands the ensemble to 22 substates. This shift extends to interstrand interaction networks: the rIAPP R18H mutant increases interaction types by 60% (to 97), whereas S20p nearly doubles them to 113. Such enriched plasticity and more complex intermolecular interactions might correlate with altered aggregation kinetics. These observations position sequence variations as molecular “dials” that fine-tune both structural diversity and functional outputs, defying the notion of mutations as mere disruptors of native folds. The authors also report the remodeling effect of mutations and PTMs on the energetic landscapes of inter-β-strand interactions within the β-sheets formed by hIAPP. Four types of variants are observed to profoundly remodel the topography, the weighted average energy, and the root-mean-square roughness of the energy funnel adopted by the hIAPP β-sheet. In contrast to classical models, STM studies reveal that β-sheet assemblies comprise a dynamic conformational ensemble of metastable substates. These conformational landscapes are remodeled by mutations and PTMs, underscoring their inherent plasticity (Figure).

By establishing a predictive “sequence–conformational ensemble–property” framework, the authors reveal that β-sheet assemblies generate structural diversity 2 orders of magnitude greater than sequence variation alone.? This dramatic expansion arises from combinatorial interplay: each of the >10 substates per variant engages in ∼10 distinct interactions, creating vast interaction repertoires.

This mechanistic insight bridges amyloid pathology and molecular evolution; the plasticity enabling pathogenic strain diversity in Alzheimer’s and prion diseases may drive functional innovation in natural protein systems.

For instance, ensembles mimicking allosteric regulation could yield smart materials responsive to pH, temperature, or ligand binding. In therapeutics, targeting conformational landscapes rather than monomeric structures may combat amyloidosis more effectively; small molecules stabilizing nonpathogenic substates could halt toxic aggregation. Moreover, the study recontextualizes amyloid “disorder” as a latent functional reservoir. Although β-sheet chaos underlies neurodegeneration, it also encodes untapped potential for catalysis, molecular sensing, and evolvable nanodevices. This duality mirrors the role of genetic mutations as drivers of both disease and innovation.

This research represents a paradigm shift in structural biology, dismantling the artificial dichotomy between order and disorder.? Their relevant work reveals that the conformational ensembles as well as the interpeptide interactions of hIAPP are found to evolve with time in the growth and plateau phases of aggregation.? By redefining amyloid aggregates as sophisticated, evolvable systems, their work illuminates a path toward harnessing conformational plasticity for biomedical and technological breakthroughs. As we move beyond the static “structure–function” dogma, the next frontier lies in decoding the language of conformational landscapes, presumably a universal grammar governing protein behavior from ancient evolutionary innovations to modern disease mechanisms. This study not only answers long-standing questions but also frames new ones: How do cells exploit conformational chaos to regulate signaling networks? Can we design synthetic ensembles with evolutionary capacity? The answers, much like the proteins themselves, will emerge from dynamic exploration of nature’s most versatile molecular ecosystems.